596 related articles for article (PubMed ID: 11207263)
1. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
2. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract.
Yamamoto M; Rennert P; McGhee JR; Kweon MN; Yamamoto S; Dohi T; Otake S; Bluethmann H; Fujihashi K; Kiyono H
J Immunol; 2000 May; 164(10):5184-91. PubMed ID: 10799877
[TBL] [Abstract][Full Text] [Related]
3. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant.
Gärdby E; Wrammert J; Schön K; Ekman L; Leanderson T; Lycke N
J Immunol; 2003 Jan; 170(1):55-63. PubMed ID: 12496383
[TBL] [Abstract][Full Text] [Related]
4. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
[TBL] [Abstract][Full Text] [Related]
5. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
6. Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.
Suzuki H; Sekine S; Kataoka K; Pascual DW; Maddaloni M; Kobayashi R; Fujihashi K; Kozono H; McGhee JR; Fujihashi K
Gastroenterology; 2008 Sep; 135(3):917-25. PubMed ID: 18565333
[TBL] [Abstract][Full Text] [Related]
7. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
[TBL] [Abstract][Full Text] [Related]
8. Evidence for early aging in the mucosal immune system.
Koga T; McGhee JR; Kato H; Kato R; Kiyono H; Fujihashi K
J Immunol; 2000 Nov; 165(9):5352-9. PubMed ID: 11046071
[TBL] [Abstract][Full Text] [Related]
9. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
[TBL] [Abstract][Full Text] [Related]
10. CD47-deficient mice have decreased production of intestinal IgA following oral immunization but a maintained capacity to induce oral tolerance.
Westlund J; Livingston M; Fahlén-Yrlid L; Oldenborg PA; Yrlid U
Immunology; 2012 Mar; 135(3):236-44. PubMed ID: 22070457
[TBL] [Abstract][Full Text] [Related]
11. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection.
Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY
J Immunol; 1996 Jun; 156(11):4290-7. PubMed ID: 8666800
[TBL] [Abstract][Full Text] [Related]
12. RANTES potentiates antigen-specific mucosal immune responses.
Lillard JW; Boyaka PN; Taub DD; McGhee JR
J Immunol; 2001 Jan; 166(1):162-9. PubMed ID: 11123289
[TBL] [Abstract][Full Text] [Related]
13. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
[TBL] [Abstract][Full Text] [Related]
14. Peyer's patches are required for oral tolerance to proteins.
Fujihashi K; Dohi T; Rennert PD; Yamamoto M; Koga T; Kiyono H; McGhee JR
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3310-5. PubMed ID: 11248075
[TBL] [Abstract][Full Text] [Related]
15. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
16. Impaired mucosal immune responses in interleukin 4-targeted mice.
Vajdy M; Kosco-Vilbois MH; Kopf M; Köhler G; Lycke N
J Exp Med; 1995 Jan; 181(1):41-53. PubMed ID: 7807021
[TBL] [Abstract][Full Text] [Related]
17. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.
Xu-Amano J; Kiyono H; Jackson RJ; Staats HF; Fujihashi K; Burrows PD; Elson CO; Pillai S; McGhee JR
J Exp Med; 1993 Oct; 178(4):1309-20. PubMed ID: 8376936
[TBL] [Abstract][Full Text] [Related]
18. Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.
Elson CO; Ealding W
J Immunol; 1984 Jun; 132(6):2736-41. PubMed ID: 6233359
[TBL] [Abstract][Full Text] [Related]
19. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.
Yamamoto S; Kiyono H; Yamamoto M; Imaoka K; Fujihashi K; Van Ginkel FW; Noda M; Takeda Y; McGhee JR
Proc Natl Acad Sci U S A; 1997 May; 94(10):5267-72. PubMed ID: 9144226
[TBL] [Abstract][Full Text] [Related]
20. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice.
Kweon MN; Fujihashi K; VanCott JL; Higuchi K; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1998 Feb; 160(4):1687-93. PubMed ID: 9469425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
